Vyndaqel 20 MG capsule UD 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F9BWK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 120 units of Vyndaqel 20 mg capsules under firm fixed pricing, with a ceiling value of $14,592.57. The award was made on December 19, 2025, with an ultimate completion date of January 13, 2026. This non-set-aside, competitively awarded contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyndaqel (tafamidis) is a prescription medication used to treat transthyretin (TTR) amyloidosis, representing AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to the federal government's military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This master contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract awards with the DLA demonstrate its established capability to competitively meet federal procurement requirements across multiple therapeutic domains, with delivery orders ranging significantly in value to support diverse military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F9BWK?
SPE2DR26F9BWK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9BWK worth?
The government has obligated $14,593 on SPE2DR26F9BWK.
Is contract SPE2DR26F9BWK an order under another contract?
Yes. SPE2DR26F9BWK is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BWK competed?
The extent of competition for SPE2DR26F9BWK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award